ARIXTRA. 2.5 mg. / 0.5 ml. 10 ampules

INDICATIONS:
Prevention of VTE in patients undergoing major orthopedic surgery of the lower limbs such as hip fracture, major knee surgery or operations for hip replacement surgery.
Prevention of venous thromboembolism in patients undergoing abdominal surgery who are judged high risk of thromboembolic complications, such as patients undergoing abdominal cancer surgery.
Prevention of venous thromboembolism in nonsurgical patients in certain high risk for VTE and who are immobilized due to acute illness such as heart failure and / or acute respiratory disease and / or acute infectious or inflammatory disease.
CONTRAINDICATIONS:
- Hypersensitivity to the active substance or to any of the excipients
- Active clinically significant bleeding
- Acute bacterial endocarditis
- Severe renal impairment defined by creatinine clearance <20 ml / min
Method of administration
Fondaparinux is administered by deep subcutaneous injection while the patient is lying down. Application sites in the abdominal wall should alternate between the left and right anterolateral and left and right postlateralno. To avoid the loss of medicinal product when using the pre-filled syringe do not expel the air bubble from the syringe. Needle should be inserted perperdikulyarno into a skin fold held between the thumb and forefinger, the skin fold should be held throughout the injection.